Thomas Russo’s Celgene Corp CELG Stock Holding History

Thomas Russo’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	-$52K	–	179
2017 Q4	$52K	Buy	+500	New	+$56.4K	﹤0.01%	156

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Thomas Russo's CELG Position: Q1 2018 in Review

Thomas Russo sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 500 shares — an estimated $52K sold.

Thomas Russo first reported a position in CELG in Q4 2017 and held it in 1 quarter. The position peaked at $52K in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Thomas Russo reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Thomas Russo sold 500 Celgene Corp shares in Q1 2018, an estimated $52K.
Thomas Russo first reported a position in Celgene Corp in Q4 2017 and held it in 1 quarter.
Thomas Russo's Celgene Corp position peaked at $52K in Q4 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Gardner Russo & Quinn's 13F filing for Q1 2018, filed 11 May 2018.